# ETHACRYNIC ACID
> **ANDA211232** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-08-27
## Drug
- **FDA Application Number:** ANDA211232
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ETHACRYNIC ACID
- **Generic name:** ETHACRYNIC ACID
- **Active ingredients:** ETHACRYNIC ACID
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals Inc
- **First approval:** 2019-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211232)
---
*AI Analytics · CC0 1.0*